Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Larry Levine
February 26, 2026 Jeff Cross

Escaping the Cleaning Industry’s Race to the Bottom

February 25, 2026 Carlos Albir Jr.

Advance the Cleaning Industry With Transparency

February 24, 2026 Juan Catoni

Cross Contamination Is Not Inevitable

Sponsored Articles

U.S. Battery Celebrates its 100-Year History
February 13, 2026

U.S. Battery Celebrates its 100-Year History

January 30, 2026

US 31DC XC2 12V Battery

January 30, 2026

US 305N XC2 6V Battery

Recent News

hugging a monitor

Most Workers Are Clinging to Their Jobs

Wisconsin Joins WHO’s Global Outbreak Response Network

Cleaning for a Reason Charity Introduces the Debbie Sardone Scholarship